MétaCan
Menu
Back to cohort
Record W3133906896

Design, Conduct and Use of Patient Preference Studies in the Medical Product Life Cycle

2019· article· en· W3133906896 on OpenAlexaboutno aff
Eline van Overbeeke, Rosanne Janssens, Chiara Whichello, Karin Schölin Bywall, Jenny Sharpe, Nikoletta Nikolenko, Berkeley Phillips, Paolo Guiddi, Gabriella Pravettoni, Laura Vergani, Laurence J. Marton, Irina Cleemput, Steven Simoens, Jürgen Kübler, Juhaeri Juhaeri, Bennett Levitan, Esther W. de Bekker‐Grob, Jorien Veldwijk, Isabelle Huys

Bibliographic record

VenueRePub (Erasmus University, Rotterdam) · 2019
Typearticle
Languageen
FieldPharmacology, Toxicology and Pharmaceutics
TopicPharmaceutical industry and healthcare
Canadian institutionsnot available
Fundersnot available
KeywordsStakeholderPreferenceFocus groupProduct (mathematics)Health technologyMarketingInclusion (mineral)BusinessHealth carePatient participationMedicineKnowledge managementPsychologyPublic relationsPolitical scienceComputer scienceEconomicsSocial psychology
DOInot available

Abstract

fetched live from OpenAlex

Objectives: To investigate stakeholder perspectives on how patient preference studies \n(PPS) should be designed and conducted to allow for inclusion of patient preferences in \ndecision-making along the medical product life cycle (MPLC), and how patient preferences \ncan be used in such decision-making. \nMethods: Two literature reviews and semi-structured interviews (n = 143) with healthcare \nstakeholders in Europe and the US were conducted; results of these informed the design \nof focus group guides. Eight focus groups were conducted with European patients, \nindustry representatives and regulators, and with US regulators and European/Canadian \nhealth technology assessment (HTA) representatives. Focus groups were analyzed \nthematically using NVivo. \nResults: Stakeholder perspectives on how PPS should be designed and conducted \nwere as follows: 1) study design should be informed by the research questions and patient \npopulation; 2) preferred treatment attributes and levels, as well as trade-offs among \nattributes and levels should be investigated; 3) the patient sample and method should \nmatch the MPLC phase; 4) different stakeholders should collaborate; and 5) results from \nPPS should be shared with relevant stakeholders. The value of patient preferences in \ndecision-making was found to increase with the level of patient preference sensitivity of \ndecisions on medical products. Stakeholders mentioned that patient preferences are hardly \nused in current decision-making. Potential applications for patient preferences across \nindustry, regulatory and HTA processes were identified. Four applications seemed most \npromising for systematic integration of patient preferences: 1) benefit-risk assessment \nby industry and regulators at the marketing-authorization phase; 2) assessment of major contribution to patient care by European regulators; 3) cost-effectiveness analysis; and 4) \nmulti criteria decision analysis in HTA. \nConclusions: The value of patient preferences for dec

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.202
metaresearch head score (Gemma)0.191
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesMetaresearch
DomainCandidate signal: Methods · Consensus signal: none
Study designCandidate signal: Theoretical or conceptual · Consensus signal: none
GenreCandidate signal: Methods · Consensus signal: none
Teacher disagreement score0.798
Threshold uncertainty score0.984

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.2020.191
Meta-epidemiology (narrow)0.0010.002
Meta-epidemiology (broad)0.0010.002
Bibliometrics0.0030.003
Science and technology studies0.0030.002
Scholarly communication0.0050.004
Open science0.0030.005
Research integrity0.0030.003
Insufficient payload (model declined to judge)0.0120.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.649
GPT teacher head0.508
Teacher spread0.141 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; the direct Gemma label and the distilled Codex classifier agree on what is shown here.

Study designTheoretical or conceptual
DomainMethods
GenreMethods

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2019
Admission routes1
Has abstractyes

Explore more

Same venueRePub (Erasmus University, Rotterdam)Same topicPharmaceutical industry and healthcareFrench-language works237,207